# sadhukhan-gynecological-cancer-2026
# [Exploring MicroRNA-Mediated Pathways in Gynecological Cancer Progression and Therapeutic Resistance]

Published in: *[MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy. Advances in Biochemistry in Health and Disease, vol 34. Springer, Cham]* Publisher: **Springer Nature**

## ðŸ”— Official Access
View the full chapter on SpringerLink: [Click Here to Access](https://doi.org/10.1007/978-3-032-08824-6_17)

## ðŸ“ Abstract
[MicroRNAs (miRNAs) are small noncoding RNAs that regulate gene expression by binding to target mRNAs, leading to their degradation or translational repression. Their dysregulation has been widely implicated in the development and progression of gynecological cancers, including ovarian, cervical, endometrial, and vulvar cancers. miRNAs influence crucial cellular processes such as cell cycle control, apoptosis, autophagy, angiogenesis, and metastasis by targeting key signaling pathways like PI3K/Akt, TGF-Î², and MAPK. Recent findings also highlight the role of exosomal miRNAs in shaping the tumor microenvironment and contributing to resistance against chemotherapy and radiotherapy. This resistance is often mediated through altered expression of tumor suppressor genes and oncogenes, leading to therapeutic failure. ]

## ðŸ“Š Supplemental Materials
* **Data:** [exosomal miRNAs in shaping the tumor microenvironment and contributing to resistance against chemotherapy and radiotherapy]
* **Figures:** See the `Pages 379-400` folder for more information.

## ðŸŽ“ Citation
If you use this work, please cite it as:
> [Srija Sadhukhan], "[Exploring MicroRNA-Mediated Pathways in Gynecological Cancer Progression and Therapeutic Resistance]," in *[MicroRNAs: Role in Cancer Progression, Diagnostics and Therapy]*, Springer, 2026.
